News

The UK spends more of its healthcare budget on cardiovascular disease than any other country in the European Union, the figures, published in the journal Heart, show. The

UK researchers from South West Kent Primary Care Trust and the University of Bradford looked at 203 females aged from 13 to 20 who got the medication from

This finding comes from a new study conducted in part by researchers at the US National Institutes of Health’s (NIH’s) National Institute of Diabetes and Digestive and Kidney

The company said in a statement that the deal recognizes “the increasing importance of biotechnology in medical research” and that the company plans to establish itself as a

A recent analysis of trial data is said to have shown that Paxil increases the risk of suicide in young adults with major depressive disorder compared to placebo.

The primary objective of this trial is to determine a dose range for the drug that is well tolerated, achieves pharmacologically active plasma concentrations and is appropriate for

The collaboration will initially focus on developing diagnostic tests for genetic variations linked to heart attack, type 2 diabetes and breast cancer. The alliance will employ Illumina's platform

The new Keflex (cephalexin) 750mg strength provides healthcare professionals a more convenient way to deliver a total daily dose of 1500mg per day, through the ability to use

The rights Inovio has licensed include two patents with broad claims regarding electroporation of nucleic acids in muscle and tumor tissue. The license also includes grants of rights